2m 2m 2m 2m 2m 2m 2m
AngioDynamics (ANGO)
NASDAQ
$14.28-$0.51 (-3.48%)
Price as of Aug 03, 2026 9:03 AM EDT- $611.3MMarket Cap
- 72.78%1-Year Change
- Medical Instruments & SuppliesIndustry
AngioDynamics (ANGO)
$14.28-$0.51 (-3.48%)
Annual
Quarterly
05/31/2026 | 05/31/2025 | 05/31/2024 | 05/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 320.2M +9.46% | 292.5M -3.76% | 303.9M -10.28% | 338.8M +7.13% | |
Cost of Revenue | 145.3M +7.78% | 134.8M -9.67% | 149.2M -9.29% | 164.5M +9.32% | |
Gross Profit | 174.9M +10.90% | 157.7M +1.94% | 154.7M -11.22% | 174.2M +5.14% | |
Sales and Marketing Expense | 113.4M +9.95% | 103.1M +0.31% | 102.8M -1.37% | 104.2M +9.39% | |
Research and Development Expense | -29.4M +12.30% | -26.2M -16.79% | -31.5M +5.45% | -29.9M -2.78% | |
Depreciation and Amortization Expense | 23.0M -11.03% | 25.8M -6.90% | 27.7M -10.24% | 30.9M +5.19% | |
Total Operating Expenses | 214.8M +8.68% | 197.7M -50.79% | 401.6M +78.16% | 225.4M +16.08% | |
Operating Profit | -39.9M -0.07% | -40.0M -79.24% | -192.4M +275.99% | -51.2M +79.77% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -299,000 N/A | N/A N/A | -1.6M -40.27% | -2.7M +292.73% | |
Interest Income and Expense and Net | -299,000 N/A | 0 +100.00% | -1.6M -40.27% | -2.7M +292.73% | |
Total Nonoperating Income and Expense | 3.9M -20.59% | 4.9M +705.14% | -817,000 +47.47% | -554,000 -29.87% | |
Income before Taxes | -36.3M +6.66% | -34.0M -82.24% | -191.6M +252.04% | -54.4M +81.77% | |
Income Taxes | 442,000 +1,233.33% | -39,000 -99.46% | -7.3M +265.36% | -2.0M -41.36% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -36.7M +8.09% | -34.0M -81.56% | -184.3M +251.53% | -52.4M +97.54% | |
Net Income from Continuing Operations Applicable to Common | -36.3M +6.66% | -34.0M -82.24% | -191.6M +252.04% | -54.4M +81.77% | |
Basic EPS and Net Income | -0.88 +6.02% | -0.83 -81.92% | -4.59 +245.11% | -1.33 +95.59% | |
Diluted EPS and Net Income | -0.88 +6.02% | -0.83 -81.92% | -4.59 +245.11% | -1.33 +95.59% | |
Basic Weighted Average Shares | 41.5M +1.65% | 40.9M +1.67% | 40.2M +1.78% | 39.5M +1.21% | |
Diluted Weighted Average Shares | 41.5M +1.65% | 40.9M +1.67% | 40.2M +1.78% | 39.5M +1.21% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 53.9M -3.63% | 55.9M -26.51% | 76.1M +70.45% | 44.6M +54.80% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 53.9M -3.63% | 55.9M -26.51% | 76.1M +70.45% | 44.6M +54.80% | |
Total Current Assets | 163.4M -2.93% | 168.3M -12.90% | 193.3M +18.17% | 163.5M +14.09% | |
Accumulated Depreciation | 80.7M +13.49% | 71.1M +2.07% | 69.7M +18.04% | 59.0M +15.58% | |
Property and Plant and Equipment and Net | 27.1M -16.11% | 32.3M -9.44% | 35.7M -19.64% | 44.4M -1.38% | |
Total Long-Term Assets | 9.5M -9.04% | 10.4M -8.49% | 11.4M +6.49% | 10.7M -2.62% | |
Total Assets | 267.2M -4.63% | 280.1M -11.81% | 317.7M -40.36% | 532.6M -3.64% | |
Income Taxes Payable | 476,000 -10.36% | 531,000 +2.12% | 520,000 +8.33% | 480,000 -36.00% | |
Total Short-Term Debt | 0 N/A | 0 N/A | N/A N/A | 25.0M N/A | |
Total Current Liabilities | 74.7M -1.94% | 76.2M -16.41% | 91.2M +8.74% | 83.8M +12.78% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 49.8M +99.27% | |
Total Long-Term Liabilities | 16.3M -3.54% | 16.9M +5.14% | 16.1M +379.94% | 3.4M -29.27% | |
Total Liabilities | 96.3M -0.86% | 97.2M -13.30% | 112.1M -27.38% | 154.3M +20.33% | |
Retained Earnings | -465.9M +8.56% | -429.2M +8.60% | -395.2M +87.43% | -210.9M +33.10% | |
Total Stockholders Equity | 170.8M -6.64% | 183.0M -11.00% | 205.6M -45.65% | 378.3M -10.88% | |
Total Shares Outstanding | 41.7M +1.72% | 41.0M +1.39% | 40.4M +2.07% | 39.6M +1.12% | |
Cash Flow | |||||
Cash from Operating Activities | 3.1M +130.50% | -10.1M -64.03% | -28.2M -36,200.00% | 78,000 +101.08% | |
Capital Expenditures | 2.6M -42.18% | 4.5M +77.28% | 2.5M -33.95% | 3.8M -11.29% | |
Cash from Investing Activities | -5.9M -41.55% | -10.2M -108.23% | 123.7M +1,369.41% | -9.7M -49.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 564,000 +321.18% | -255,000 -99.60% | -64.2M -352.75% | 25.4M +230.86% | |
Financials Ratio | |||||
Gross Margin | 54.62% +1.31% | 53.92% +5.92% | 50.90% -1.04% | 51.44% -1.86% | |
Operating Margin | -12.47% -8.71% | -13.66% -78.43% | -63.32% +319.09% | -15.11% +67.81% | |
Return on Assets | -13.43% +18.06% | -11.37% -73.77% | -43.36% +348.71% | -9.66% +102.78% | |
Return on Equity | -20.77% +18.71% | -17.50% -72.29% | -63.15% +383.32% | -13.06% +112.59% | |
Revenue Growth | 9.46% +351.89% | -3.76% -63.48% | -10.28% -244.32% | 7.13% -17.74% | |
Current Ratio | 2.19 -1.01% | 2.21 +4.20% | 2.12 +8.66% | 1.95 +1.16% | |
Cash Ratio | 0.72 -1.72% | 0.73 -12.09% | 0.83 +56.75% | 0.53 +37.26% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.20 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.14 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow